Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside).

Source:http://linkedlifedata.com/resource/pubmed/id/15534203

Proc. Natl. Acad. Sci. U.S.A. 2004 Nov 16 101 46 16204-9

Download in:

View as

Triples

General Info

PMID
15534203